Why has the EU not approved Russia’s Sputnik jab?
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Sunday
January 29, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
SUNDAY, JANUARY 29, 2023
Why has the EU not approved Russia’s Sputnik jab?

Coronavirus chronicle

BSS/AFP
20 February, 2021, 10:30 am
Last modified: 20 February, 2021, 10:59 am

Related News

  • Forget 'autonomy': Europe needs the US as much as ever
  • Hungary will veto EU sanctions on Russia on nuclear energy
  • The German Due Diligence Act: Are we ready?
  • EU wants to send more people back to Africa, Middle East, Asia
  • EU must do more to tackle antibiotic shortages, say patient groups

Why has the EU not approved Russia’s Sputnik jab?

Russian authorities tout the vaccine’s take-up by around 30 countries and a Lancet study showing it was 91.6 percent effective against symptomatic Covid-19 cases

BSS/AFP
20 February, 2021, 10:30 am
Last modified: 20 February, 2021, 10:59 am
Empty vials of the Sputnik V (Gam-COVID-Vac) vaccine are pictured at the San Martin hospital, in La Plata, on the outskirts of Buenos Aires, Argentina January 18, 2021. REUTERS/Agustin Marcarian
Empty vials of the Sputnik V (Gam-COVID-Vac) vaccine are pictured at the San Martin hospital, in La Plata, on the outskirts of Buenos Aires, Argentina January 18, 2021. REUTERS/Agustin Marcarian

Russia's Sputnik V vaccine is still waiting for the European Medicines Agency (EMA) to start the countdown to its launch across the 27-nation bloc.

With Moscow and Brussels trading barbs over the length of time the Amsterdam-based regulator is taking, here is what we know so far:

What's The Process? 

The EMA says Sputnik faces the same process as all other coronavirus vaccines.

This first stage is a "rolling review" of data and trials, which the EMA says Sputnik has not started.

That would be followed by a formal application for a one-year conditional marketing authorisation.

"They have to submit the whole set of data, indeed go through the whole scrutiny process, like any other vaccine," European Commission chief Ursula von der Leyen said on February 17 about Sputnik.

Three vaccines are authorised for the EU: Pfizer-BioNTech, Moderna and AstraZeneca. One other, Johnson & Johnson, has applied for authorisation. Two others, Novavax and CureVac, have started rolling reviews.

What Does The EMA Say?

The EMA insisted in a "clarification" on February 10 that it had "to date not received an application for a rolling review or a marketing authorisation for… the Sputnik V vaccine, despite reports stating the opposite."

The regulator confirmed to AFP that was still the case on February 18.

It also said that EMA's experts themselves "need to give their agreement first before developers can submit their application for initiation of the rolling review process."

The EMA has however said that Sputnik V's backers submitted a request for "scientific advice" to prepare for a possible application for market authorisation, and confirmed a meeting took place on January 19 to discuss "further engagement".

What Do The Russians Say?

Russian authorities tout the vaccine's take-up by around 30 countries and a Lancet study showing it was 91.6 percent effective against symptomatic Covid-19 cases.

The developers and backers of Sputnik insist that a rolling review application has been made.

The Russian sovereign wealth fund, which backed the vaccine, said Russian authorities "filed a registration request" on January 19 — further than the step the EMA said was taken on that date.

The fund also rejected "misdirected" reports that, after Sputnik's Twitter account posted a supposed filing of the registration, it turned out it had been sent to the wrong agency.

The fund insisted it was "working with the EMA to start a rolling review" and said the agency had a few days ago "appointed rapporteurs for the Sputnik V dossier".

Is Sputnik Being Treated The Same As Other Vaccines?

As it would be the first non-Western developed vaccine deployed in the EU, officials have said that Sputnik production sites outside the bloc would need to be inspected.

"They are not producing in Europe, so of course there should be an inspection process on the production sites," von der Leyen said on February 17.

Brussels has been wary of Russian and Chinese vaccines, concerned that Moscow and Beijing would use them as soft power tools.

Von der Leyen herself raised questions about why Moscow was so keen to push the vaccine on the EU.

"Overall I must say, we still wonder why Russia is offering theoretically millions and millions of doses while not sufficiently progressing in vaccinating their own people," she said.

Explainer / Top News / World+Biz

Sputnik Covid-19 Vaccine / Sputnik V COVID-19 vaccine / Sputnik V vaccine / Sputnik vaccine trial / Sputnik V / Russian vaccine / EU / Europe

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Mumit M/TBS
    Biz leaders want crisis management, energy security for survival
  • A proper price formula can help investors to plan big
    A proper price formula can help investors to plan big
  • SK Bashir Uddin: TBS sketch
    Investments risky without consistent policy, reliable data

MOST VIEWED

  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  •  A medical worker checks the IV drip treatment of a patient lying on a bed in the emergency department of a hospital, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China, January 5, 2023. REUTERS/Staff
    China says Covid deaths down by nearly 80 percent
  • Sean Bagley, 14, receives the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    Updated Covid vaccines prevented illness from latest variants -CDC
  • People embrace at the international arrivals gate at Beijing Capital International Airport after China lifted the coronavirus disease (COVID-19) quarantine requirement for inbound travellers in Beijing, China January 8, 2023. REUTERS/Thomas Peter
    China says peak Covid infections exceeded 7 million daily, deaths more than 4,000 daily

Related News

  • Forget 'autonomy': Europe needs the US as much as ever
  • Hungary will veto EU sanctions on Russia on nuclear energy
  • The German Due Diligence Act: Are we ready?
  • EU wants to send more people back to Africa, Middle East, Asia
  • EU must do more to tackle antibiotic shortages, say patient groups

Features

Snipe in flight. Photo: Enam Ul Haque

Baikka Beel: 'A world where snipe work late'

14h | Panorama
Photo: Noor-A-Alam

Pet cafes: Where love for food and animals cohabit

16h | Food
Illustration: TBS

How MFS is turbocharging national economy

18h | Thoughts
Now is the time to focus on FDI composition

Now is the time to focus on FDI composition

20h | Panorama

More Videos from TBS

What does Shahrukh has in his 770 million dollar property?

What does Shahrukh has in his 770 million dollar property?

9h | TBS Entertainment
15 Reasons Your Entrepreneurial Career Can Fail

15 Reasons Your Entrepreneurial Career Can Fail

8h | TBS Career
Women are going to make history in match management in cricket

Women are going to make history in match management in cricket

7h | TBS SPORTS
Gold covered mummy discovered in Egypt

Gold covered mummy discovered in Egypt

13h | TBS World

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Four top bankers arrested in DSA case filed by S Alam group 
Bangladesh

Four top bankers arrested in DSA case filed by S Alam group 

3
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

4
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

5
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]